US Stock MarketDetailed Quotes

LAZ Lazard

Watchlist
  • 49.935
  • +0.355+0.72%
Trading Feb 27 10:42 ET
4.49BMarket Cap18.63P/E (TTM)

Lazard Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lazard Q4 2024 Earnings Date

Currency：USDJan 30, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
754.14M
839.02M
+84.87M
Beat Est.
-0.90%
+1.61%
+11.25%
EPS
0.46
0.80
+0.34
Beat Est.
-28.54%
+23.08%
+72.23%
Analyst Rating
Hold

Feb 9, 2025

Lazard Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 755.428M--
--2025/Q1-- / 705.699M--
Jan 30, 20252024/Q4812.433M / 754.144M--
Oct 31, 20242024/Q3645.914M / 649.087M--
Jul 25, 20242024/Q2684.642M / 638.743M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 755.428M--
--2025/Q1-- / 705.699M--
Jan 30, 20252024/Q4812.433M / 754.144M--
Oct 31, 20242024/Q3645.914M / 649.087M--
Jul 25, 20242024/Q2684.642M / 638.743M--

Unlock Free Earnings Estimates

Lazard Earnings Reports

  • Lazard | 10-K: FY2024 Annual Report

    Feb 24 17:22 ET

  • Lazard | 8-K: LAZARD REPORTS FOURTH-QUARTER AND FULL-YEAR 2024 RESULTS

    Jan 30 06:36 ET

  • Lazard | 10-Q: Q3 2024 Earnings Report

    Nov 1, 2024 16:37 ET

  • Lazard | 8-K: LAZARD REPORTS THIRD-QUARTER AND NINE-MONTH 2024 RESULTS

    Oct 31, 2024 06:41 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.78%
    Halozyme Therapeutics
    HALO
    +1.34%
    Collegium Pharmaceutical
    COLL
    +1.27%
    Hutchmed (China)
    HCM
    +0.78%
    Precision Drilling
    PDS
    +0.16%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 9, 2025

    Hold

    • Buy

      28.57%

    • Hold

      57.14%

    • Sell

      14.29%

    Price Target

    No Data